Related references
Note: Only part of the references are listed.STAT3α interacts with nuclear GSK3beta and cytoplasmic RISK pathway and stabilizes rhythm in the anoxic-reoxygenated embryonic heart
Sarah Pedretti et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning
Sophie Tamareille et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
FoxO Transcription Factors Promote Cardiomyocyte Survival upon Induction of Oxidative Stress
Arunima Sengupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
Katherine J. E. Sattler et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
TNFα protects cardiac mitochondria independently of its cell surface receptors
Lydia Lacerda et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Ethanolamine is a novel STAT-3 dependent cardioprotective agent
Roisin F. Kelly et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion
Kerstin Boengler et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Silent Information Regulator 1 Protects the Heart From Ischemia/Reperfusion
Chiao-Po Hsu et al.
CIRCULATION (2010)
TNF alpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure
Petra Kleinbongard et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway
Lydia Lacerda et al.
CARDIOVASCULAR RESEARCH (2009)
Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: Role of sphingosine-1-phosphate
Miguel A. Frias et al.
CARDIOVASCULAR RESEARCH (2009)
Ischemic Postconditioning in Pigs No Causal Role for RISK Activation
Andreas Skyschally et al.
CIRCULATION RESEARCH (2009)
被撤回的出版物: Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol (Retracted article. See vol. 53, pg. 641, 2012)
Subhendu Mukherjee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Sphingosine Kinase and Sphingosine 1-Phosphate in Cardioprotection
Joel S. Karliner
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?
Sandrine Lecour
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Wegrzyn et al.
SCIENCE (2009)
Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion
Britt N. Fuglesteg et al.
BASIC RESEARCH IN CARDIOLOGY (2008)
Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia
Donald A. Vessey et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning
Naushaad Suleman et al.
CARDIOVASCULAR RESEARCH (2008)
The myocardial JAK/STAT pathway: From protection to failure
Kerstin Boengler et al.
PHARMACOLOGY & THERAPEUTICS (2008)
HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects
Kelley M. Argraves et al.
JOURNAL OF LIPID RESEARCH (2007)
Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of lnterleukin-6-type cytokine signaling
Mazen Kurdi et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury
Christopher K. Means et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor
Gregor Theilmeier et al.
CIRCULATION (2006)
Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling
Yan G. Ni et al.
CIRCULATION (2006)
Pharmacological preconditioning with tumor necrosis factor-α activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase)
S Lecour et al.
CIRCULATION (2005)
Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry
EV Berdyshev et al.
ANALYTICAL BIOCHEMISTRY (2005)
Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate
MG Sanna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning
RM Smith et al.
CARDIOVASCULAR RESEARCH (2004)
Mechanisms of cardioprotection by lysophospholipids
JS Karliner
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via SS1P2
T Ohmori et al.
CARDIOVASCULAR RESEARCH (2003)
Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFα gene
RM Smith et al.
CARDIOVASCULAR RESEARCH (2002)
Identification of a novel role for sphingolipid signaling in TNFα and ischemic preconditioning mediated cardioprotection
S Lecour et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion
E Mascareno et al.
CIRCULATION (2001)
Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions
N Murata et al.
BIOCHEMICAL JOURNAL (2000)
Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction
S Negoro et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
